Lumenis UK – Now offering the Geneo X in our direct portfolio

March 19^th 2025 – Lumenis BE UK, a global leader in energy-based medical solutions, is pleased to announce that it is now taking direct orders for Geneo X and its consumable capsules. This exciting development streamlines the purchasing process, ensuring faster delivery and enhanced customer support for clinics and practitioners across the UK.

Geneo X is a cutting-edge facial treatment platform that provides advanced skincare solutions through its innovative oxygenation and ultrasound technology. With its unique OxyPods and highly effective serums, Geneo X delivers immediate and long-lasting results, making it a preferred choice for beauty professionals worldwide.

By offering direct ordering, Lumenis BE UK aims to improve accessibility, reduce lead times, and provide dedicated support to professionals integrating Geneo X into their treatment offerings. Customers can now conveniently order their devices and consumables directly from Lumenis UK, ensuring authenticity, quality assurance, manufacturer warranty and best-in-class service support.

As part of this launch, Lumenis are excited to offer an introductory discount of 10% off list price for all consumable capsules for orders placed before the end of day on Monday 31^st March 2025.

“We are excited to bring this direct ordering opportunity to our customers in the UK” said Daniel Schleider, Business Director at Lumenis EMEA. “This initiative reinforces our commitment to providing premium skincare solutions with exceptional service, allowing beauty professionals to access the latest in facial technology with greater ease and efficiency.”

For more information or to place an order, please contact Lumenis BE UK Customer Care by email at customercareuk@lumenis.com or by phone on +44(0)20 4536 5418.

About Lumenis
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology, and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For 50 years, Lumenis’ ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods. visit:  www.lumenis.co.uk